Latest News and Press Releases
Want to stay updated on the latest news?
-
San Francisco, CA, May 15, 2026 (GLOBE NEWSWIRE) -- Zerion releases Zerion CLI, an open-source toolkit that gives AI agents native access to crypto portfolios, swaps, bridges, and transaction...
-
Nes-Ziona, Israel, May 15, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), a quality longevity company powered by a prediction markets treasury, today announced...
-
BOCA RATON, Fla., May 15, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (Nasdaq: GNLN), a publicly traded company with a digital asset treasury strategy focused on...
-
KOBE, Japan, May 15, 2026 (GLOBE NEWSWIRE) -- Micware Co., Ltd. (Nasdaq: MWC) (the “Company” or “Micware”), a Japan-based provider of software development services and innovative IT solutions mainly...
-
- Continued advancement of the ongoing Phase 1 study of RT-114 via RaniPill® for the treatment of obesity in collaboration with ProGen – - Appointed Alireza Javadi, Ph.D. as Chief Technical Officer -...
-
Irving, TX, May 15, 2026 (GLOBE NEWSWIRE) -- Breeze Acquisition Corp. II (NASDAQ: BREZU) (the “Company”) announced today the closing of the underwriters’ partial exercise of the over-allotment...
-
CORONA, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Monster Beverage Corporation (NASDAQ:MNST) today announced that its Board of Directors has authorized a new share repurchase program for the...
-
SUNNYVALE, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Cerebras Systems Inc. (“Cerebras”) today announced the closing of its initial public offering of an aggregate of 34,500,000 shares of its Class A...
-
Completed Formal Dispute Resolution Meeting with FDA regarding Complete Response Letter (CRL) for ONS-5010; Decision Expected This Month Continued expansion of LYTENAVA™ (bevacizumab gamma) in Europe...
-
Expion360 Reports First Quarter 2026 Financial and Operational Results